Serial SOFA-score trends in ICU-admitted COVID-19 patients as predictor of 28-day mortality: A prospective cohort

Farzad Esmaeili Tarki1, Siamak Afaghi2, Fatemeh Sadat Rahimi3

  • 1Research Department of Internal Medicine Shahid Beheshti University of Medical Sciences Tehran Iran.

Abstract

Insights

The Sequential Organ Failure Assessment (SOFA) score, particularly the mean score within the first 96 hours, can predict 28-day mortality in ICU COVID-19 patients. However, it is less accurate than established factors like age and comorbidities.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • The predictive value of the Sequential Organ Failure Assessment (SOFA) score for clinical outcomes in ICU-admitted COVID-19 patients remains debated.
  • This study investigates the SOFA score's efficacy in predicting 28-day mortality compared to established COVID-19 risk factors.

Purpose of the Study:

  • To assess the predictive capability of SOFA scores at various time points for 28-day mortality in COVID-19 patients admitted to the ICU.
  • To compare the predictive accuracy of SOFA scores with well-recognized risk factors for COVID-19 mortality.

Main Methods:

  • An observational prospective cohort study included 1057 patients from March 2020 to March 2022.
  • Univariate and multivariate Cox proportional analyses were used to evaluate SOFA score models.
  • Receiver operating characteristic (ROC) curves were employed to determine predictive values.

Main Results:

  • Mean SOFA score within the first 96 hours (HR: 3.82), highest SOFA score (HR: 2.70), and initial SOFA score (HR: 1.65) showed significant association with 28-day mortality (p < .0001).
  • Mean SOFA score remained an independent prognosticator (HR: 2.28) but had lower predictive value than age, hypertension, coronary artery disease (CAD), and diabetes mellitus.
  • The area under the ROC curve was highest for mean SOFA score (0.77) and highest SOFA score (0.71). An increasing SOFA trend within 96 hours predicted >50% fatality.

Conclusions:

  • The mean SOFA score within the first 96 hours of ICU stay is a reliable predictor of 28-day mortality in COVID-19 patients.
  • However, its accuracy is inferior to established predictors like age, diabetes mellitus, hypertension, and CAD.
  • An increasing SOFA score trend during the initial 96 ICU hours indicates a high fatality rate, irrespective of the initial score.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
296
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
256
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
239
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
172
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
14
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
295